Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(16)30305-9
PubMed Identifier: 27686943
Publication URI: http://europepmc.org/abstract/MED/27686943
Type: Journal Article/Review
Parent Publication: The Lancet Oncology
Issue: 11
ISSN: 1470-2045